ESSA Pharma (NASDAQ:EPIX) Share Price Crosses Above 50-Day Moving Average – Time to Sell?

ESSA Pharma Inc. (NASDAQ:EPIX) (TSE:EPI) shares crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $5.63 and traded as high as $6.34. ESSA Pharma shares last traded at $6.04, with a volume of 42,416 shares.

ESSA Pharma Trading Down 0.2 %

The business’s fifty day moving average price is $5.63 and its two-hundred day moving average price is $6.10. The firm has a market cap of $267.95 million, a P/E ratio of -9.59 and a beta of 1.83.

ESSA Pharma (NASDAQ:EPIX) (TSE:EPI) last posted its earnings results on Monday, August 5th. The company reported ($0.16) EPS for the quarter, topping the consensus estimate of ($0.26) by $0.10. Research analysts predict that ESSA Pharma Inc. will post -0.71 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in EPIX. EntryPoint Capital LLC acquired a new position in ESSA Pharma during the first quarter valued at approximately $38,000. Janus Henderson Group PLC lifted its stake in shares of ESSA Pharma by 7.9% in the first quarter. Janus Henderson Group PLC now owns 1,175,242 shares of the company’s stock worth $9,978,000 after buying an additional 85,760 shares during the last quarter. Finally, RTW Investments LP bought a new stake in shares of ESSA Pharma during the 4th quarter worth $15,171,000. 75.12% of the stock is owned by institutional investors.

ESSA Pharma Company Profile

ESSA Pharma Inc, a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer.